Table:
|  | Years Ended December 31, |  |
| --- | --- | --- |
|  | 2019 | 2018 |
| Net cash provided by (used in) operating activities from continuing operations | $47,899 | $151,427 |
| Net cash provided by (used in) operating activities from discontinued operations | 493 | (156) |
| Net cash provided by (used in) operating activities | 48,392 | 151,271 |
| Net cash provided by (used in) investing activities from continuing operations | (393,847) | (113,592) |
| Net cash provided by (used in) financing activities from continuing operations | 338,840 | (97,134) |
| EFFECT OF CURRENCY TRANSLATION ON CASH | (1,496) | (1,030) |
| INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (8,111) | (60,485) |
| CASH AND CASH EQUIVALENTS, beginning of period | 354,552 | 415,037 |
| CASH AND CASH EQUIVALENTS, end of period | 346,441 | 354,552 |
| Less cash and cash equivalents from discontinued operations | — | 5,251 |
| CASH AND CASH EQUIVALENTS FROM CONTINUING OPERATIONS, end of period | $346,441 | $349,301 |
Paragraphs:
Share Repurchase
On December 18, 2019, the Board of Directors authorized to remove the expiration date to the Company’s common stock share repurchase program and increase the authorized amount by $25.1 million increasing the authorization to repurchase shares up to a total of $50.0 million. As of December 31, 2019, a total of $50.0 million remained available for future share repurchases. We repurchased 1.7 million shares for $95.1 million and 0.4 million shares for $30.0 million in fiscal 2018 and 2017, respectively. There were no shares repurchased in fiscal 2019. CASH FLOWS
A summary of our cash provided by and used in operating, investing, and financing activities is as follows (in thousands):
Question:
What did the Board of Directors authorize in 2019?
Answer: to remove the expiration date to the Company’s common stock share repurchase program and increase the authorized amount by $25.1 million increasing the authorization to repurchase shares up to a total of $50.0 million.